Tags

Type your tag names separated by a space and hit enter

The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV.
Clin Infect Dis. 2021 Jul 22 [Online ahead of print]CI

Abstract

Previous studies have shown that certain vaccines induce suboptimal responses in people living with HIV (PLWH). However, responses to SARS-CoV-2 vaccines have not been fully characterized in these patients. Here we show that the BNT162b2 vaccine induces robust immune responses comparable to responses in healthy donors.

Authors+Show Affiliations

Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD, USA.Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, MD, USA.Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34293114

Citation

Woldemeskel, Bezawit A., et al. "The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With HIV." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, 2021.
Woldemeskel BA, Karaba AH, Garliss CC, et al. The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV. Clin Infect Dis. 2021.
Woldemeskel, B. A., Karaba, A. H., Garliss, C. C., Beck, E. J., Wang, K. H., Laeyendecker, O., Cox, A. L., & Blankson, J. N. (2021). The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. https://doi.org/10.1093/cid/ciab648
Woldemeskel BA, et al. The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With HIV. Clin Infect Dis. 2021 Jul 22; PubMed PMID: 34293114.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living with HIV. AU - Woldemeskel,Bezawit A, AU - Karaba,Andrew H, AU - Garliss,Caroline C, AU - Beck,Evan J, AU - Wang,Kristy H, AU - Laeyendecker,Oliver, AU - Cox,Andrea L, AU - Blankson,Joel N, Y1 - 2021/07/22/ PY - 2021/06/22/received PY - 2021/7/22/entrez PY - 2021/7/23/pubmed PY - 2021/7/23/medline KW - COVID KW - PLWH KW - SARS-CoV-2 KW - mRNA vaccine JF - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America JO - Clin Infect Dis N2 - Previous studies have shown that certain vaccines induce suboptimal responses in people living with HIV (PLWH). However, responses to SARS-CoV-2 vaccines have not been fully characterized in these patients. Here we show that the BNT162b2 vaccine induces robust immune responses comparable to responses in healthy donors. SN - 1537-6591 UR - https://www.unboundmedicine.com/medline/citation/34293114/The_BNT162b2_mRNA_Vaccine_Elicits_Robust_Humoral_and_Cellular_Immune_Responses_in_People_Living_with_HIV. L2 - https://academic.oup.com/cid/article-lookup/doi/10.1093/cid/ciab648 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.